Company profile: ABL
1.1 - Company Overview
Company description
- Provider of biotechnology contract research, development, and manufacturing services.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ABL
IDEA Pharma
HQ: United States
Website
- Description: Provider of strategic marketing, portfolio and disease area strategy, positioning, scenario planning and communication strategy for pharmaceutical companies, including path-to-market strategies addressing clinical, regulatory and commercial challenges; innovation strategy; strategic pharmaceutical positioning; Immersion, Design, Evaluation, Acceleration insights; and the annual Pharmaceutical Innovation and Invention Index.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDEA Pharma company profile →
Pharsight
HQ: United States
Website
- Description: Provider of software and scientific consulting services to pharmaceutical and biotechnology companies in the United States, Europe, and internationally, offering products including Phoenix WinNonlin and WinNonMix for statistical analysis and mathematical modeling of pharmacokinetic (PK)/pharmacodynamic data, and Trial Simulator.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharsight company profile →
Leinco Technologies
HQ: United States
Website
- Description: Provider of monoclonal antibodies and protein tools for life science research, diagnostics, therapeutics, and flow cytometry, including primary, secondary, and in vivo functional grade antibodies; PhenoCycler-Fusion barcoded antibodies; flow cytometry reagents; recombinant proteins; streptavidin products; and cytokines to support early discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Leinco Technologies company profile →
MedPanel
HQ: United States
Website
- Description: Provider of research-based market insights to corporate and financial healthcare clients, delivering custom qualitative and quantitative research for product commercialization (study design, recruitment, moderation, data analysis). Offers recruitment for non-interventional clinical trials, rare disease consulting, research and recruitment, and live/asynchronous online panel discussions that bring healthcare professionals together for deeper insights.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedPanel company profile →
Pyramid Laboratories
HQ: United States
Website
- Description: Provider of contract parenteral drug product manufacturing and analytical services for the pharmaceutical and biotechnology industries, including aseptic vial and syringe filling, lyophilization, formulation and process development, clinical supply manufacturing, commercial fill/finish, and labeling, storage, and global distribution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyramid Laboratories company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ABL
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ABL
2.2 - Growth funds investing in similar companies to ABL
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ABL
4.2 - Public trading comparable groups for ABL
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →